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Abstract: A bifunctional 
aldolase/kinase enzyme named DLF 
has been constructed by gene fusion 
through overlap extension. This fusion 
enzyme consists of monomeric 
fructose-1,6-bisphosphate aldolase 
(FBPA) from Staphylococcus carnosus 
and the homodimeric dihydroxyacetone 
kinase (DHAK) from Citrobacter 
freundii CECT 4626 with an 
intervening five amino acid linker. The 
fusion protein was expressed soluble 
and retained both kinase and aldolase 
activities. The secondary structure of 
the bifuctional enzyme has been 
analysed by CD spectroscopy, as well 
as that of the parental enzymes, in order 
to study the effect of the covalent 
coupling of the two parent proteins on 
the structure of the fused enzyme. Since 
S. carnosus FBPA is a thermostable 
protein, the effect of the fusion on the 
thermal stability of the bifunctional 
enzyme has also been studied. The 
proximity of the active centres in the 
fused enzyme promotes a kinetic 
advantage as the 20-fold increment in 
the initial velocity of the overall aldol 
reaction indicates. Experimental 
evidence supports that this increase in 
the reaction rate can be explained in 
terms of substrate channelling. 
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Introduction 
The aldol addition reaction has long been recognized as one of the 
most useful tools that has the synthetic chemist for the construction 
of new carbon–carbon bonds.[1] Concomitant with the C–C bond 
forming process is the formation of one or two new stereocenters, 
allowing to approach synthesis of a broad range of both natural and 
novel compounds. Aldolases are among the most important 
biocatalysts used by the Nature for C–C bond formation. 
Dihydroxyacetone (DHA) phosphate dependent aldolases have been 
thoroughly used to synthesize carbohydrates, carbohydrate-like 
structures, or non-carbohydrate compounds.[2] Their major synthetic 
advantage is that the stereochemistry of the two newly formed 
stereogenic centers is controlled by the enzymes and moreover, they 
are stereocomplementary, in that they can synthesize the four 
possible diastereoisomers of vicinal diols from achiral aldehyde 
acceptors and DHAP. However it’s also well known that their major 
drawback is their strict specificity for DHAP. Besides the scope 
limitation that this fact represents, DHAP is expensive to be used 
stoichiometrically in high-scale synthesis and labile at neutral and 
basic pH, which causes that its effective concentration diminishes 
with time in the enzymatic reaction media. Efforts to overcome 
DHAP dependence of aldolases have involved in situ formation of 
arsenate or borate esters of DHA, which act as phosphate ester 
mimics,[3] the use of Enzyme Directed Evolution strategies to 
modify their donor substrate specificity,[4] development of catalytic 
antibodies and small peptides with aldolase activity,[5] de novo 
design of retro-aldol enzymes[6] and the use of newly discovered 
enzymes.[7] Besides these efforts, an efficient method of DHAP 
preparation is still essential and several chemical and enzymatic 
routes of DHAP synthesis have been described in the literature.[8] 
With respect to chemical synthesis, those starting from the DHA 
dimer[9] or 1,3-dibromoacetone,[10] provide a stable precursor of 
DHAP. On the other hand, enzymatic preparation of DHAP is 
usually coupled with the aldolic condensation catalyzed by the 
aldolase. Thus, DHAP can be prepared by oxidation of L-glycerol 3-
phosphate (L-G3P) catalyzed by glycerophosphate oxidase, coupled 
with hydrogen peroxide decomposition by catalase.[11] Later on, this 
multi-enzyme system has been coupled with in situ preparation of 
D,L-G3P either by phosphorylation of glycerol catalyzed by the 
phosphatase phytase,[12] or by regioselective opening of the rac-
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glycidol epoxide ring with phosphate.[13] A cascade reaction for the 
in situ generation of DHAP using the acid phosphatase from 
Shigella flexneri and pyrophosphate (PPi) as phosphoryl donor has 
also been described.[14] Direct kinase-catalysed phosphorylation of 
DHA using ATP as phosphoryl donor constitutes another strategy to 
obtain DHAP. This approach was first described in 1983 by Wong 
and Whitesides using the enzyme glycerol kinase.[15] Yeast ATP-
dependent DHAK’s have also been used for the simple and efficient 
preparation of DHAP.[16]  
Our research group has developed a straightforward multi-
enzyme system for one-pot C-C bond formation catalysed by 
DHAP-dependent aldolases that allows the use of DHA as initial 
donor. This system is based on the use of the recombinant ATP-
dependent DHAK from C. freundii CECT 4626 for the in situ 
phosphorylation of DHA.[17] This enzyme has the highest catalytic 
efficiency for DHA phosphorylation described in the literature.[18] 
The multi-enzyme system was completed with the regeneration of 
ATP catalysed by acetate kinase (Scheme 1). This multi-enzyme 
system is attractive since it is a one-pot/one-step route to the 
phosphorylated aldol adduct and we have showed its utility with the 
three synthetically useful DHAP-dependent aldolases and with a 
great variety of commercially available aldehydes.[17]  
 
Scheme 1. Multi-enzyme system for C-C bond formation catalysed by DHAP-
dependent aldolases, based in the in situ phosphorylation of DHA catalysed by DHAK 
from C. freundii. 
However, there are at least two aspects that can be optimized: 
i. The number of enzymes that take part on the system. 
Although the different enzymes can be overproduced in 
recombinant organisms, the purification of proteins is 
widely recognized as technically and economically 
challenging, accounting for a substantial fraction of the total 
manufacturing cost, being one of the limiting step in 
bioprocess development.[19]  
ii. The high sensitivity of the ATP regeneration system to pH 
and organic solvents.[17b]  
Herein, we offer an approach to solve the first point. One way to 
reduce the number of enzymes to express and purify is to splice two 
or more enzymatic activities in only one polypeptide creating a 
hybrid or fusion enzyme.[20] Fusion proteins have great number of 
applications in biotechnology, ranging from analytical procedures[21] 
to metabolic engineering,[22] being the purification of proteins a 
main application.[23] The use of fusion proteins in biotransformation 
may have another, even more interesting effects due to the physical 
association of enzymes that catalyse sequential reactions into 
covalently linked complexes. The close proximity of active sites of 
two enzymes in multi-enzyme complexes can provide a substantial 
substrate channelling contribution, in addition to the random 
diffusion path.[24] Some of the potential catalytic advantages of 
substrate channelling include: i) decrease of the transit time required 
for an intermediate to reach the active site of the subsequent 
enzyme; ii) reduction of the transient time for the system to reach 
the new steady state; iii) protection of chemically labile 
intermediates; iv) circumvention of unfavorable equilibria and 
kinetics imposed by bulk-phase metabolite concentrations and v) 
segregation of the intermediates from competing chemical and 
enzymatic reactions.[24,25] In spite of these numerous potential 
advantages, fusion enzymes have been scarcely used in the 
biotransformation field.[26]  
In the present work, we have engineered a bifunctional enzyme 
(named DLF), which joins the aldolase and the kinase activities in 
the same polypeptide.[27] We describe here the design, expression 
and the structural and functional characterization of this new 
biocatalyst. 
Results and Discussion 
Design of the fused aldolase/kinase enzyme: A key point at the 
moment of designing a fusion protein is to consider the possible 
interactions between subunits that can take place in the context of 
the chimera. When two monomeric proteins are fused, it is expected 
that the resultant fusion protein keeps the monomeric character of 
the parent enzymes. However, if the parent proteins have a dimeric 
or oligomeric character, the quaternary structure of the fusion 
protein is difficult to predict and the possible formation of 
macromolecular complexes of different size and activities can be 
obtained (Scheme 2).[20a] 
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Scheme 2. Representation of the quaternary structure that can acquire a fused protein 
depending on the oligomeric nature of the parental proteins (adapted from ref. 20a). 
Since DHAK from C. freundii is a dimeric enzyme,[28] we have 
chosen, as aldolase partner, the fructose-1,6-bisphosphate (FBP) 
aldolase from Staphylococcus carnosus because of its monomeric 
structure.[29] This aldolase belongs to the class I, which mechanism 
of reaction proceed through the formation of a Schiff-base 
intermediate between the donor substrate and a highly conserved 
lysine residue in the active site of the enzyme. In addition, this 
aldolase has a high pH and temperature stability.[29a] Kula and co-
workers postulate that both stabilities are result of its monomeric 
structure and of a high renaturation potential. The crystal structure 
of FBPA from S. carnosus is unknown but the protein has a high 
degree of identity (55%) with the enzyme from Porphyromonas 
gingivals, which crystal structure has been resolved.[30] Figure 1 
represents the 3D structure of FBPA from S. carnosus modeled by 
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the SWISS-MODEL server[31] using as template the structure of the 
enzyme from P. gingivals. 
 
Figure 1. 3D structure of the FBPA from S. carnosus modelled by the SWISS-MODEL 
server. The putative catalytic lysine is showed in ball and sticks. 
Another key point in the designing of a fusion protein is the 
selection of the linker sequence. Linker length and sequence 
composition can affect folding and activity of the chimeric protein. 
The linker sequence that has been selected to join the aldolase and 
the kinase enzymes was designed with the aid of the LINKER 
program.[32] The linker has to be long enough and sufficiently 
flexible to allow for the proper folding of each protein domain but 
short enough to keep the active sites close, in order to invigorate 
possible substrate channelling effects. In this sense, sequences with 
preference to adopt extended conformation are more desirable than 
sequences with high propensity to adopt α-helix or β-strand 
structures, which could limit the flexibility of the system. We fixed 
arbitrarily a five amino acids length for the linker sequence and a 
series of sequence filters such as the absence of polar, charged or 
hydrophobic residues, were introduced in the LINKER program. 
With this input, LINKER automatically generated a set of three 
peptide sequences known to adopt extended conformations (Figure 
2). The sequence Gln-Gly-Gln-Gly-Gln was chosen because the 
DNA coding sequence does not contain restriction sites for the 
enzymes XhoI and NdeI chosen for the cloning of the fusion 
enzyme; it is a so flexible sequence that must allow the native 
folding of the fused enzymes and it is short enough to keep close the 
kinase and aldolase active centers. 
 
Figure 2. 3D structure of the three peptide sequences generated by the LINKER 
program. The structure shown is the one that these peptides present in the context of 
their corresponding protein. 
Finally, since the C-terminal of FBPA is closer to the active 
center that the N-terminal end, we decided to carry out the fusion 
through this end. Therefore, the designed construction of the new 
bifunctional enzyme was DHAK-Linker-FBPA (Scheme 3). 
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Scheme 3. Disposition of the different elements in the designed bifunctional 
aldolase/kinase enzyme (DLF). 
Construction and characterization of the bifunctional DLF 
enzyme: To construct the bifunctional DLF enzyme, the genes dhak 
from C. freundii and fda from S. carnosus were ‘spliced’ together by 
overlap extension.[33] This method comprises two PCR steps. In the 
first PCR step, the dhak and fda genes were amplified separately 
including sites for the restriction enzymes NdeI (5’-dhak) and XhoI 
(3’-fda). Extremes 3’-dhak and 5’-fda included the 15 nucleotides 
coding for the linker sequence (l). These amplified genes were used 
as templates in a second PCR step (Figure 3). 
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Figure 3. Strategy used for dhak and fda gene splicing by overlap extension. 
The construction dhak-l-fda (2565 bp) was cloned into the pET-
28b(+) expression vector that include a N-terminal histidine tag 
extending the recombinant protein. SDS-PAGE analysis of DLF 
expression in E. coli BL21(DE3) showed that DLF was expressed 
soluble and represented 75% of the total protein with a productivity 
of 135 and 425 U/L of culture broth for the kinase and aldolase 
activities respectively (ratio kinase:aldolase activities 1:3). 
DLF was purified by immobilized metal affinity 
chromatography (IMAC) followed by size-exclusion 
chromatography. Peptide mass fingerprinting verified that the 
purified protein had the DLF expected features. Twenty peptides 
covering the DHAK sequence and 13 peptides covering the FBPA 
sequence were identified (Figure 4). 
 4
SQFFFNQRTHLVSDVIDGTIIASPWNNLARLESDPAIRIVVRRDLNKNNVAVISGGGSGHEPAHVGFIGKGMLT
AAVCGDVFASPSVDAVLTAIQAVTGEAGCLLIVKNYTGDRLNFGLAAEKARRLGYNVEMLIVGDDISLPDNKHP
RGIAGTILVHKIAGYFAERGYNLATVLREAQYAANNTFSLGVALSSCHLPQEADAAPRHHPGHAELGMGIHGEP
GASVIDTQNSAQVVNLMVDKLMAALPETGRLAVMINNLGGVSVAEMAIITRELASSPLHPRIDWLIGPASLVTA
LDMKSFSLTAIVLEESIEKALLTEVETSNWPTPVPPREISCVPSSQRSARVEFQPSANAMVAGIVELVTTTLSD
LETHLNALDAKVGDGDTGSTFAAGAREIASLLHRQQLPLDNLATLFALIGERLTVVMGGSSGVLMSIFFTAAGQ
KLEQGASVAESLNTGLAQMKFYGGADEGDRTMIDALQPALTSLLTQPQNLQAAFDAAQAGAERTCLSSKANAGR
ASYLSSESLLGNMDPGAHAVAMVFKALAESELGQGQGQNQEQFDKIKNGKGFIAALDQSGGSTPKALKDYGVEE
NEYSNDEEMFNLVHDMRTRIITSPAFNGEKILGAILFEQTMDREVEGKYTGSYLADKGIVPFLKVDKGLAEEAD
GVQLMKPIPDLDKLLDRANERGIFGTKMRSNILENNKEAIEKVVKQQFEVAKEIIAAGLVPIIEPEVNINAKDK
EAIEANLAEAIKAELDNLKKDQYVMLKLTIPTKVNAYSELIEHPQVIRVVALSGGYSRDEANKILKQNDGLIAS
FSRALVSDLNAQQSDAEFNEKLQEAIDTIFDASVNKA 
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Figure 4. Peptide mass fingerprint of bifunctional DLF. The sequence of the identified 
peptides are shaded and underlined. Molecular mass of each peptide is indicated in Da. 
Linker sequence is underlined. 
Sedimentation equilibrium analysis of the purified protein 
confirmed the expected molecular weight and showed that the 
fusion protein was a homodimer, as native DHAK (Figure 5). 
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Figure 5. Sedimentation equilibrium analysis of FBPA (●) and DLF (○). 
To analyse the effect of the covalent coupling of DHAK and 
FBPA in the fused enzyme, we compare its kinetic behaviour and 
secondary structure with those from the parent enzymes. 
The kinetic parameters of DLF enzyme were calculated 
independently for DHA phosphorylation, to analyse the kinase 
activity, and for the retro-aldol reaction of fructose-1,6-bisphosphate 
to evaluate the aldolase activity. DLF showed a Michaelis-Menten 
kinetic for both activities as did the parent enzymes. The covalent 
union of both enzymes did not modify substantially either the KM or 
the kcat of DLF aldolase activity (Table 1). On the other hand, both 
constants were slightly modified on DLF kinase activity (Table 1). 
The KM increase and the kcat decrease of about three times, results in 
a loss of catalytic efficiency (kcat/KM) of the kinase activity in the 
fusion enzyme of about one order of magnitude. This loss in 
catalytic efficiency could be a direct result of the entropy loss of the 
two active sites in the bifunctional enzyme compared with the 
independent proteins. Apart of this, it cannot be discarded that some 
active centers of the kinase had lost accessibility for the substrate in 
the fusion enzyme. However, despite this decrease, the kcat/KM value 
for this activity in the fusion enzyme, in the order of 106 (s-1/M), is 
high enough to allow its use in C-C coupling reactions. 
Table 1. Summary of the kinetic constants of the bifunctional DLF and of the parent 
enzymes. 
   DLF 
 DHAK[a] FBPA[b] kinase aldolase[b] 
KM (M) 1.22x10-6 1.46x10-5 3.80x10-6 1.88x10
-5 
kcat (s-1) 24.13 16.76 8.16 20.30 
kcat/KM (s-1/M) 1.98x107 1.16x104 1.19x106 1.08x10
4 
[a] Constant determined for DHA phosphorylation; data taken from reference 18. [b] 
Constant determined in retro-aldol reaction with FBP as substrate. 
Circular dichroism (CD) study of DLF secondary structure: The 
far-UV CD spectra obtained for the fused and the parent enzymes 
are indicative of a predominantly α-helical structure with two 
minima at ~208 and ~222 nm (Figure 6a). 
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Figure 6. CD spectra at 20 ºC of (a) DHAK (?), FBPA (?) and DLF (?) and (b) 
equimolar mixture of DHAK and FBPA. 
The contribution of each type of secondary structure is 
summarized in Table 2.  
Table 2. Summary of the contribution of the different secondary structures components 
in DHAK, FBPA, DLF and DHAK:FBPA mixture. 
 α-Helix[a] β-Sheet[a] Turns[a] Unordered[a] 
DHAK 41.4 ±0.95 13.2 ±0.93 16.8 ±0.46 28.2 ±1.95 
FBPA 67.2 ±3.16 5.0 ±2.80 11.4 ±3.05 17.4 ±4.20 
DLF 46.2 ±1.81 11.2 ±0.98 16.2 ±0.65 26.0 ±1.54 
Mixture[b]     
Exp.[c] 52.7 ±2.50 8.3 ±0.46 15.0 ±1.33 24.7 ±1.80 
Calc.[d] 53.39 10.86 15.72 25.75 
[a] Contribution of each type of secondary structure is expressed in percentage. [b] 
Equimolar DHAK:FBPA mixture. [c] Values obtained from the CD spectra of the 
DHAK:FBPA mixture. [d] Values calculated applying eqn. 1 (see Experimental section) 
to the data obtained for the parent DHAK and FBPA enzymes. 
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Figure 7. Variation with the temperature of the CD spectra at 222 nm of (a) DHAK, (b) FBPA and (c) DLF. 
From the CD spectra of DHAK and FBPA, one can calculate the 
structural composition of an equimolar mixture of these enzymes 
(eq. 1; see Experimental Section). The calculated values should 
match the structural composition of DLF if the fusion has no 
significant effect on the folding of the fused protein domains. DLF 
has a contribution of α-helix (46.2 % ± 1.81) slightly lower than 
expected for the mixture of DHAK and FBPA (Table 2). In order to 
determine whether this small difference could be due to the fusion 
of both enzymes or to unspecific non-covalent interactions between 
them, the CD spectrum of an equimolar mixture of DHAK and 
FBPA was recorded (Figure 6b). As can be observed in Table 2, the 
contribution of each secondary structure component calculated from 
the CD spectra of the enzyme mixture, agreed with the values 
obtained applying equation 1. We conclude that the covalent union 
of both proteins is responsible for this minor reduction in α-helical 
conformation. 
Is thermostability of FBPA transferred to the fused DLF 
enzyme?: As it has been commented previously, FBPA from S. 
carnosus has a considerable thermostability.[29a] Therefore, it was 
interesting to investigate whether this thermostability has been 
somehow transferred to the fusion enzyme. 
Thermal stability of the three enzymes (DHAK, FBPA and 
DLF) was initially assessed using CD by following the temperature 
dependence of dichroism signal at 222 nm (Figure 7). From these 
curves the melting temperature (Tm) of the proteins can be 
calculated if they fit a two-state folding model (equation 2; see 
Experimental section).[34] The curve following thermal unfolding of 
DHAK (Figure 7a) could be fitted to a simple thermodynamic 
unfolding model. The melting temperature (midpoint of the 
transition) was determined to be 49.9 ± 0.1 °C. In addition, the 
transition region was very narrow and sharp, indicating that the 
protein existed initially as a compact, well-folded structure and that 
the unfolding reaction was highly cooperative. The DLF curve 
(Figure 7c) also responds to a two-state unfolding model, with a 
melting temperature of 51.8 ± 0.25 ºC, significantly higher than the 
Tm calculated for DHAK. On the other hand, although somewhat 
less narrow and sharp than that of the DHAK, the width and shape 
of the transition region corresponds also to a initially well-folded 
structure and a cooperative melting process. However, the behavior 
of FBPA was completely different (Figure 7b). The curve clearly 
suggested the existence of two transitions and therefore it did not fit 
to a simple thermodynamic unfolding model. Hence, we decided to 
analyse the thermal denaturation of FBPA in terms of “fraction of 
unfolding” (fu),[35] that is defined here as the fraction of the total loss 
of α-helix that has occurred at each particular temperature. For 
comparative purposes we apply the same analysis to DHAK and 
DLF. As can be deduced from Figure 8, the Tm calculated for 
DHAK and DLF from the temperature dependence of the fraction of 
unfolding (48.7 ºC and 53.7 ºC respectively) are consistent with the 
Tm calculated from the melting curves in Figure 7. Figure 8 also 
shows that the melting temperature of the fusion enzyme DLF is 
almost coinciding with that of FBPA (54.9 ºC). 
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Figure 8. Thermal denaturation profiles of (?) DHAK, FBPA (?) and DLF (?). 
As we did in the study of the secondary structure, to evaluate if 
the behavior of the fused enzyme was due to the covalent union of 
DHAK and FBPA or just to the simultaneous presence of both 
proteins, we studied the thermal denaturation of an equimolar 
mixture of DHAK and FBPA (Figure 9). Thermal denaturation of 
the mixture fit a two-state folding model with a transition region 
wider than those of DHAK and DLF, which is consistent with the 
presence of a heterogeneous population of folded structures. On this 
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occasion we found a disparity of 5 ºC between the Tm calculated 
from the CD spectrum at 222 nm (44.2 ± 0.5 ºC) (Figure 9a) and 
that calculated from the fraction of unfolding (49.3 ºC) (Figure 9b). 
Anyway, both values are lower than the Tm calculated for the fused 
enzyme (53.7 ºC). Therefore, the covalent union of FBPA and 
DHAK allows the thermostability of FBPA to be transferred, at least 
in part, to the fusion protein, making of DLF a more thermostable 
biocatalyst than the multi-enzyme system. 
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Figure 9. Thermal denaturation profiles of a equimolar mixture of DHAK and FBPA. 
(a) Dichroism at 222 nm, (b) variation of fraction of unfolding (?) with temperature. 
The denaturation profile of DLF (?) is included for comparative purposes. 
However, the Tm is directly related to conformational stability 
only if the unfolding is fully reversible. Irreversibility of the melting 
reaction is usually associated with protein precipitation or 
aggregation as it is unfolded. If this is the case, the melting 
temperature will not only depend on the intrinsic conformational 
stability but also on the kinetics of aggregation and the solubility of 
the unfolded form of the molecule. As can be observed in Figure 10, 
only FBPA showed an almost complete recuperation (92 %) of the 
secondary structure after denaturation at 90 ºC (Figure 10b). On the 
contrary, DHAK only recovered 51 % of its original secondary 
structure (Figure 10a), showing that this protein tends to precipitate 
and/or aggregates after denaturing. This result can be explained by 
the particular structure of DHAK. This protein is a homodimer and 
each subunit is formed by two domains clearly differentiated.[28] The 
K-domain is where the DHA binding site is located and the L-
domain bears the ATP binding site. The ATP binding domain is a 
barrel formed by eight amphipathic α-helices stabilized by a 
phospholipid molecule (Figure 11). The loss of this lipid after 
unfolding could explain the tendency of DHAK to aggregate. One 
more time we could observe that the fusion was not neutral. Thus, 
the behavior of the equimolar mixture of DHAK and FBPA (Figure 
10d) is practically the average between DHAK and FBPA unfolding 
(the mixture recovered 70 % of its original secondary structure). 
However, the fused enzyme DLF has a quite similar behavior to 
DHAK (Figure 10c) with an almost irreversible unfolding, although 
the percentage of recovered original structure (54 %) is slightly 
higher than the DHAK. This indicates that unfolding of the DHAK 
domain dominates the thermotropic behavior of the full chimeric 
construct. 
Finally, to analyze if there was a correspondence between the 
structural stability studied by CD and the operational stability of the 
enzymes, we determine their functional half-life at 45 ºC (Fig. 12). 
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Figure 10. CD spectra at 20 ºC (?), 90 ºC (?) and again at 20 ºC after cooling the 
sample from 90 ºC (?) of (a) DHAK, (b) FBPA, (c) DLF and (d) equimolar mixture of 
DHAK and FBPA. 
 
Figure 11. Crystallographic structure of the ATP binding domain from DHAK (pdb 
1un9).[28] The phospholipids molecule stabilizing the folding is represented in stick. 
To study how the fusion affected the activity of each enzyme, 
we evaluated independently the kinase and aldolase activities. 
DHAK, FBPA and DLF were incubated at 45 ºC over time and their 
remnant activities were evaluated at room temperature. We therefore 
determined in this assay the progressive loss of activity due to 
irreversible denaturation of the enzymes. The results obtained in this 
experiment were consistent with the results of the CD study. The 
half-life of the aldolase activity in the fused DLF decreased 
significantly with respect to the parent FBPA. This can be explained 
by the lower potential of renaturation of DLF with regards to FBPA. 
However, the half-life of the kinase activity significantly increased 
in the fusion enzyme with regard to the half-life of the parent 
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DHAK. This increment could be due to the higher Tm of the fusion 
enzyme. 
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Figure 12. Operational stability at 45 ºC of (?) FBPA, (?) DHAK, (?) aldolase 
activity of DLF and (?) kinase activity of DLF. 
In summary, although the aldolase activity is substantially 
destabilized compared to its parent enzyme, the kinase activity is 
markedly stabilized in the context of the fusion construct. Since the 
global thermal stability of both the multi-enzyme system and the 
fused DLF is determined by the less stable of their components, 
DLF should be considered a more thermostable biocatalyst than the 
multi-enzyme system, since the half-life of its less stable component 
(140 min for the aldolase activity) is more than double than the half-
life of the DHAK (65 min), the least stable component of the multi-
enzyme system. 
Substrate channelling: As indicated above, a very interesting effect 
of the fusion of enzymes working sequentially is an increase of their 
catalytic efficiency due to the proximity of the active centres in 
these covalently linked multi-enzyme complexes.  
Effectively, the overall rate of the coupled reaction catalysed by 
the fused DLF was 0.41 μmol/min whereas with the multi-enzyme 
system the overall rate was only of 0.02 μmol/min. That is, the 
physical association of the enzymes produces an increase in the 
aldol reaction rate of 20-folds.[27] This increase in the reaction rate 
could be explained in terms of substrate channelling. In the case of 
two free enzymes working sequentially, the product of the first 
reaction must diffuse through the bulk solution to meet the second 
enzyme. In the fusion enzyme the intermediate is directly transferred 
to the second enzyme without full diffusion and equilibration within 
the bulk solution. Therefore, DHAP produced by the kinase should 
have a lower transit time[36] to the aldolase active sites in the fusion 
enzyme compared with that of the multi-enzyme system, since the 
distance between the active centers has been significantly reduced. 
Alternatively, the obtained results can be explained from an 
increased local concentration of the intermediate DHAP in the 
proximity of the aldolase active centre producing, as a consequence, 
a concomitant increase in the reaction rate. In both cases free 
diffusion of DHAP to the bulk solution is limited. 
The possible occurrence of substrate channelling can be 
assessed by addition to the system of a third enzyme that could trap 
the intermediate. The activity of this third enzyme should be higher 
if the intermediate diffuse freely to the bulk solution than in the case 
where the diffusion of the intermediate is limited (Scheme 4).  
 
Scheme 4. Glycerol-3-phosphate dehydrogenase (GDH) catalyses the reduction of 
DHAP to glycerophosphate (a). In the multi-enzyme system where DHAP can freely 
diffuse to the bulk solution (b), the GDH activity measured must be higher than in the 
presence of the fusion enzyme (c) where DHAP is directly transferred to the aldolase 
without exposure to the bulk solution. 
We carried out this experiment using glycerol-3-phosphate 
dehydrogenase (GDH) as trapping enzyme. GDH catalyses the 
reversible reduction of DHAP to glycerol-3-phosphate with 
concomitant oxidation of NADH (Scheme 4a). As can be observed 
in Figure 13, the GDH activity measured in the presence of the 
fused DLF enzyme or of the multi-enzyme system formed by the 
parental free enzymes was significantly different. 
GDH / μg
0 5 10 15 20 25
G
D
H
 / 
U
0,00
0,02
0,04
0,06
0,08
 
Figure 13. GDH activity measured in presence of the fused DLF enzyme (?) or in 
presence of the multi-enzyme system (?). The third curve (?) represent the GDH 
activity measured in presence of a non functional DLF since the acceptor aldehyde was 
not included in the reaction mixture. 
In the presence of the fusion enzyme, the maximum GDH 
activity measured was 0.036 U with 10 μg of enzyme. With this 
same amount of GDH, the activity measured in the presence of the 
multi-enzyme system was almost twice (0.062 U). This result 
 8
indicated that GDH had more substrate (DHAP) available with the 
multi-enzyme system than with the fusion enzyme. To confirm this 
interpretation, we measured GDH activity in the presence of the 
fusion enzyme but without adding the aldehyde acceptor. As a 
consequence, the second reaction catalysed by DLF—the aldol 
addition reaction— is unviable permitting DHAP to freely diffuse to 
the bulk solution. Under these conditions, the GDH activity 
measured reached similar values than in the presence of the multi-
enzyme system (Figure 13), confirming the existence of the 
proposed channelling of DHAP in the fusion enzyme. 
Synthetic applicability of DLF: One of the key feature to ensure 
that the multi-enzyme system for one-pot C-C bond formation 
previously described by us[17] operates optimally is that DHAP must 
be produced at the same rate as it is consumed by the aldolase to 
avoid its accumulation and to minimize its non-enzymatic 
degradation. Therefore, a delicate adjustment of the aldolase/kinase 
activity ratio was necessary. However, this adjustment is not 
possible when DLF is used, since in the fusion enzyme the ratio 
kinase:aldolase (1:3) is structurally fixed. We explored if a similar 
effect could be achieved modulating the ketone/aldehyde ratio. We 
carried out this experiment using acetaldehyde (2) as acceptor. In a 
first attempt, we used a acetaldehyde/DHA ratio of 1.5/1 equivalents. 
When the reaction was carried out with DLF (0.3 U of aldolase and 
0.1 U of kinase), after 22 hours DHA had been almost completely 
consumed but only a 28% of aldol could be detected. On the other 
hand, there was considerable accumulation of DHAP (37%). That is, 
about the 35% of the produced DHAP had been degraded during the 
reaction without giving place to aldol formation. Doubling the 
amount of enzyme, we got an increase in aldol formation that 
reached the 44%, decreasing the accumulation of DHAP to 30.6% 
(Figure 14).  
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Figure 14. Figure Accumulation of DHA (?), DHAP (?) and aldol adduct (?) in the 
reaction mixture at different acetaldehyde:DHA ratios. 
With the highest acetaldehyde:DHA ratio (10:1), it was 
observed that the ATP regeneration system did not work properly 
since after 22 h. as much as a 21% of DHA remained without react. 
In these conditions the aldol formation was very poor, reaching only 
less that 20%. On the other hand, the results obtained with the ratios 
3:1 and 5: were very similar. In both cases DHA was consumed 
almost completely —the ATP regeneration system works 
correctly—, the accumulation of DHAP ranged between 10-12% 
and the formation of aldol adduct reached the 70% (Figure 14). That 
is, modulating the aldehyde:ketone ratio we have been able to 
significantly increase the efficiency of the system. For subsequent 
studies we fixed the 3:1 ratio. 
Once the optimum aldehyde:ketone ratio was determined, we 
studied the synthetic applicability of DLF using 
benzyloxyacetaldehyde (1), acetaldehyde (2) and 3-
(methylthio)propionaldehyde (3) as acceptors (Scheme 5).[27] These 
reactions were conducted in small scale reactions with increased 
amount of DLF than in the previous experiments (1.35 U of aldolase 
and 0.45 U of kinase). The percentage of aldol adducts obtained 
after 20 h. of reaction was of 58.2 for benzyloxyacetaldehyde (1), 
82.6 with acetaldehyde (2) and 67.3 with 
(methylthio)propionaldehyde (3). One more time, increasing the 
amount of DLF provoked an improvement in the yield of aldol 
formation as could be observed in the case of 5, which yield 
increased from 70% to more than 80%. 
 
Scheme 5. Scheme of DLF application to stereoselective C-C bond formation 
In a first approximation to determine if the stereoselectivity of 
the aldol reaction had been modified by the fusion process, we 
analysed the stereoisomers formed in the DLF catalysed reactions 
applying the enzymatic assay described by Sheldon and co-workers 
based on the reversibility of the aldol reaction.[37] In general, the 
results summarized in Table 3 are in agreement with those reported 
by Sheldon and co-workers for the FBPA from S. carnosus: the 
aldol reaction catalysed by DLF is highly, but far from absolutely, 
stereospecific for products with D-threo configuration and it is 
strongly influenced by the acceptor. In particular, the data regarding 
acetaldehyde (2) are not dissimilar to those reported for the same 
aldehyde by Sheldon and co-workers.[37] Therefore, we can conclude 
that the fusion process has not influence on the stereoselectivity of 
the aldol reaction. 
Table 3. Stereoisomeric ratio of products formed in DLF catalysed reactions.[a] 
Acceptor 
Stereoisomer (%)[b] 
D-threo L-threo D-erythro 
1 79.4 2.1 18.5 
2 71.8 2.0 26.2 
3 96.0 0   4.0 
[a] Only stereoisomers with D-threo, L-threo and D-erythro configuration could be 
detected. [b] Percentage was calculated with respect to the total aldol adduct formed. 
Conclusion 
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As part of our ongoing project on the development of more efficient 
and affordable biocatalyst for C-C bond formation, we have 
engineered a bifunctional enzyme able to catalyse aldol addition 
reactions using DHA as initial ketone donor. This fusion enzyme 
named DLF consists of monomeric fructose-1,6-bisphosphate 
aldolase from S. carnosus and the homodimeric dihydroxyacetone 
kinase from C. freundii CECT 4626 with an intervening five 
aminoacids linker. The fusion protein was expressed soluble and 
retained both kinase and aldolase activities with a so good catalytic 
efficiency (kcat/KM) in the order of 106 (s-1/M). The CD study 
described in this work has shown that the fusion of the parent 
enzymes affects only slightly the folding of the fused DLF enzyme. 
However, the renaturation capacity of DLF is lower than the 
expected for an equimolar mixture of the parent enzymes. These 
results could be explained because a big protein like C. freundii 
DHAK (over 120 kDa), may disturb the folding of FBPA (35 kDa), 
more over since FBPA is translated after DHAK.[38] The covalent 
union of both enzymes also allows that some of their properties are 
transferred to the fusion protein. Thus, the Tm of the fused enzyme is 
almost identical to that of FBPA and higher than would be expected 
if the fusion did not exercise any effect. On the other hand, we have 
demonstrated that the operational stability of DLF enzyme is higher 
than that of the multi-enzyme system. We have also shown that the 
physical association of the parent enzymes produces an increase in 
the aldol reaction rate of 20-folds that can be interpreted in terms of 
substrate channelling provided by the close proximity of the active 
centres occurred in the fusion enzyme. Finally, it seems that the 
fusion has not modified the steric course of the aldol reaction 
catalysed by the bifuctional DLF enzyme. 
In summary, with the described strategy we have been able to 
develop a more affordable biocatalyst, more stable and more 
efficient than the multi-enzyme system composed by the free parent 
enzymes. Work is in progress in our lab to apply this strategy to 
other DHAP-dependent aldolases. 
Experimental Section 
Materials and General Procedures: Staphylococcus carnosus CECT 4491 was 
provided from the Spanish Type Culture Collection (CECT). E. coli BL21(DE3) 
competent cells were purchased from Stratagene Co. (San Diego, CA). Restriction 
enzymes, Taq polymerase and T4-DNA ligase were purchased from MBI Fermentas 
AB (Lithuania). Triosephosphate isomerase (TIM), α-glycerophosphate dehydrogenase 
(GDH), lysostaphin and acetate kinase (AK), were purchased from Sigma-Aldrich (St. 
Louis, MO). PCR primers were purchased from Isogen Life Science (Spain) and the 
pET-28b(+) expression vector was purchased from Novagen. Isopropyl-β-D-
thiogalactopyranoside (IPTG) was purchased from Applichem GmBH (Germany). 
Plasmids and PCR purification kits were from Promega (Madison, WI) and DNA 
purification kit from agarose gels was from Eppendorf (Hamburg, Germany). SDS-
PAGE was performed using 10% and 5% acrylamide in the resolving and stacking gels, 
respectively. Gels were stained with Coomassie brilliant blue R-250 (Applichem GmBH, 
Germany). Electrophoresis was always run under reducing conditions, in the presence 
of 5% β-mercaptoethanol. Protein and DNA gels were quantified by densitometry using 
GeneGenius Gel Documentation and Analysis System (Syngene, U.K.). Nickel-
iminodiacetic acid (Ni2+-IDA) agarose was supplied by Agarose Bead Technologies 
(Spain). Size-exclusion chromatography was carried out on a HiLoad 26/60 Superdex 
75 PG column controlled using the AKTA-FPLC system (GE Healthcare Life Science). 
1H and 13C NMR spectra, using D2O as solvent, were recorded on a Varian SYSTEM 
500 spectrometer equipped with a 5 mm HCN cold probe with field z-gradient, 
operating at 500.13 and 125.76 MHz for 1H and 13C, respectively. The sample 
temperature was maintained constant at 298 K. One-dimensional NMR experiments 
were performed using standard Varian pulse sequences. Two-dimensional [1H, 1H] 
NMR experiments (gCOSY) were carried out with the following parameters: a delay 
time of 1 s, a spectral width of 3000 Hz in both dimensions, 4096 complex points in t2 
and 4 transients for each of 256 time increments, and linear prediction to 512. The data 
were zero-filled to 4096 × 4096 real points. Two-dimensional [1H-13C] NMR 
experiments (gHSQC and gHMBC) used the same 1H spectral window, a 13C spectral 
windows of 15 000 Hz, 1 s of relaxation delay, 1024 data points, and 256 time 
increments, with a linear prediction to 512. The data were zero-filled to 4096 × 4096 
real points. Typical numbers of transients per increment were 4 and 16, respectively. 
Cloning, over-expression and purification of FBPA from S. Carnosus: DNA 
manipulation was according to standard procedures.[39] DNA template for amplification 
of the fda gene was obtained from the S. carnosus strain CECT 4491. The 
oligonucleotides 5´-ATATTCATATGAACCAAGAACAACAATTTGAC-3´ and 5´-
TATTACTCGAGTTAAGCTTTGTTTACTGA-3´ were used as leftward and rightward 
primers respectively (the recognition sequence for NdeI and XhoI are underlined). To 
extract the DNA, S. carnosus cells was suspended in lysis buffer containing Tris 10 mM, 
EDTA 10 mM, lysozyme 200 U/mL and lysostaphin 25 U/mL.[40] PCR amplification 
was performed in a 10 μL reaction mixture and subjected to 25 cycles of amplification. 
The cycle conditions were set as follows: denaturation at 94ºC for 1 min, annealing at 
55 ºC for 2 min and elongation at 72 ºC for 1 min. The purified PCR product was 
digested with NdeI and XhoI and ligated into the doubled digested vector pET-28b(+) to 
yield the plasmid pET-fda. This plasmid was transformed into E. coli BL21(DE3) 
competent cells. A colony containing the plasmid pET-fda was cultured in Luria-
Bertani (LB) broth containing kanamycin (26 μg/mL) at 37 ºC with shaking. When the 
culture reached an O.D600nm of 0.5-0.6, FBPA expression was induced with IPTG (0.4 
mM) and the temperature was dropped to 30 ºC. The culture was maintained over night 
(O/N). After that, the culture was centrifuged at 3,000 x g during 30 min at 4 ºC and the 
resulting pellet was treated with lysozyme and DNase for protein extraction.[41] The 
recombinant protein containing an N-terminal 6xHis tag was purified in a Ni+2-IDA-
agarose column pre-equilibrated with sodium phosphate buffer (20 mM, pH 7.5). FBPA 
was eluted with the same buffer containing imidazole 1 M. All the fractions containing 
protein were pooled together and further purified by size-exclusion chromatography on 
a HiLoad 26/60 Superdex 75 PG column controlled using the AKTA-FPLC system (GE 
Healthcare Life Science). The column was developed in 50 mM phosphate buffer pH 
7.2 containing NaCl (0.15 M) at a constant flow rate of 1.0 mL/min 
Construction, expression and purification of the bifuctional DLF enzyme: The 
dhak-l-fda fusion gene was constructed by gene splicing through overlap extension.[33] 
The sequences of the primers used are shown in Table 4. 
Table 4. Sequences of the primers used to splice the dhak and fda genes. The 
endonuclease recognition sequences are in bold and the linker sequence underlined 
Fragment Primer Sequence 
dhak-l NtNdhak
[a] 
CtFdhak 
5’ATATTCATATGTCTCAATTCTTTTTT3’ 
5’CTGGCCCTGGCCCTGGCCCAGCTCACTCTC3’ 
l-fda CtScXfda
[b] 
NtFScfda 
5’TATTACTCGAGTTAAGCTTTGTTTACTGA3’ 
5’CAGGGCCAGGGCCAGAACCAAGAACAATTT 
  GACAAA3’ 
dhak-l-fda NtNdhak
[a] 
CtScXfda[b] 
5’ATATTCATATGTCTCAATTCTTTTTT3’ 
5’TATTACTCGAGTTAAGCTTTGTTTACTGA3’ 
[a] Restriction enzyme NdeI. [b] Restriction enzyme XhoI. 
The first two PCRs amplification were performed in 10 μL reaction mixture and 
subjected to 25 cycles of amplification. The cycle conditions were set as follows: 
denaturation at 94ºC for 1 min, annealing at 55 ºC for 1 min and elongation at 72 ºC for 
2 min. A 1:1 mixture of the purified PCR products was used as template in the second 
PCR step. The reaction conditions were identical to the previously described, except for 
the elongation time that was 3 min. After purification, the dhak-l-fda fragment was 
digested with NdeI and XhoI and ligated into the doubled digested vector pET-28b(+) to 
yield the plasmid pET-dhak-l-fda. This plasmid was transformed into E. coli 
BL21(DE3) competent cells. Procedure for expression and purification of the 
bifuctional enzyme were identical to those described for the FBPA enzyme except in the 
IMAC purification step. In this case, previously to elute the enzyme with imidazole 1 M, 
the column was washed with 10 volumes of sodium phosphate buffer (20 mM, pH 7.5) 
containing imidazole 50 mM. 
Protein analysis: Amino acid analysis of purified recombinant proteins was performed 
in the Protein Chemistry Service of the Centre of Biological Research (CIB-CSIC) to 
determine the protein concentration. The absorption spectrum of different quantified 
samples allowed determination of the molar extinction coefficient at 280 nm for 
recombinant FBPA (ε280 = 46292 M-1·cm-1) and for DLF (ε280 = 77928 M-1·cm-1). 
Peptide mass fingerprint analyses from the SDS-PAGE band corresponding to the 
putative FBPA and DLF were performed at the Proteomic Unit of the Spanish National 
Center of Biotechnology (CNB-CSIC). Samples were digested with sequencing grade 
trypsin O/N at 37 ºC. The analysis by MALDI-TOF mass spectrometry produces 
peptide mass fingerprints and the peptides observed can be collated and represented as a 
list of monoisotopic molecular weights. Data were collected in the m/z range of 800-
3600. Sedimentation equilibrium experiments were performed at the Department of 
Chemical Physics of Biological Macromolecules (Institute of Chemical Physics 
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"Rocasolano"; CSIC). The initial concentration of the protein used in these experiments 
was 0.96 mg/mL.  
Circular dichroism (CD) studies: Far-UV circular dichroism (CD) spectra were 
recorded in the wavelength range of 195-240 nm using a Jasco J-810 spectropolarimeter 
equipped with a constant temperature cell holder Jasco PTC423-S Peltier. The protein 
concentration was 0.2-0.4 mg/mL (3.1-6.2 μM) for DHAK, 0.1-0.2 mg/mL (2.9-5.8 
μM) for FBPA and 0.6-0.7 mg/mL (6.4-7.5 μM) for DLF. The optical path length was 
0.1 cm. The contribution of the buffer was always subtracted. For each sample, four 
spectra were accumulated at a scan speed of 20 nm/min with a bandwidth of 0.2 nm and 
averaged automatically. The mean residue ellipticity, [Θ], is given in units of 
deg·cm2·dmol-1. The secondary structure of the protein was evaluated by computer fit of 
the dichroism spectrum into four simple components (α-helix, β-sheet, turns and 
random coil) using the CDPro software package containing three commonly used 
programs: SELCON3, CONTIN/LL and CDSSTR (SFig. 1 and 2).[42] This software 
allows the use of different sets of proteins to increase the reliability of analyses. We 
choose the set number 4, composed of 43 soluble proteins. From data obtained for 
DHAK and FBPA, the theoretical structural composition of a equimolar mixture was 
calculated applying equation 1: 
M
FBPAFBPADHAKDHAK
M PM
PMPM ** ψψψ +=  (eqn 1) 
where ψ is each secondary structure (α-helix, β-sheet, turns or random coil) and PM is 
the molecular weight of the corresponding protein. 
Thermal stability was assessed by following changes in the entire spectrum in the far-
UV CD region with increasing temperature from 20 ºC to 90 ºC (SFig. 3). Thermal 
transition curves were obtained by monitoring DC signal at 222 nm as a function of 
temperature. The temperature gradient was 40 ºC/h and data were recorded each 0.2 ºC. 
These curves were fitted to a simple thermodynamic unfolding model (eqn. 2): 
)15273(*)15.273(*98.1
)(exp1
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−+−−+=  (eqn 2) 
where D0 is the value of the DC signal (in mdeg) of the unfolded state at T=0 ºC; mD is 
the slope of the unfolded state; N0 is the value of the DC signal (in mdeg) of the native 
state at T=0 ºC; mN is the slope of the native state; TM is the temperature (in ºC) of the 
inflection point and HD is the van’t Hoff enthalpy associated to the denaturation process 
at T=TM. 
 The fraction of unfolding, fu, at each temperature was calculated by dividing the 
amount of α-helix lost from the folded state by the total loss of α-helix (eqn. 3). 
fu = (hn-hT) / (hn-hu) (eqn 3) 
where hT is the normalized content of α-helix at a given temperature and hn and hu are 
the normalized content of α-helix at the folded and unfolded states. 
Enzyme activity assays and steady-state kinetic analysis: Phosphorylation of DHA 
was measured spectrophotometrically in a coupled enzymatic assay as previously 
described.[18] Aldolase activity was spectrophotometrically measured by the retro-aldol 
reaction using fructose-1,6-bisphosphate (FBP) as substrate.[43] The aldolase activity 
assays were run at room temperature following the decrease of absorbance at 340 nm 
(εNADH = 6220 M-1·cm-1) for 5 minutes in 1 mL reaction mixture containing Tris-HCl 
buffer (40 mM, pH 8.0), NADH (0.2 μmol), α-GDH/TIM (2 U), 1.0 μmol of FBP and 
FBPA or the bifunctional DLF. Steady-state kinetic assays with DLF were measured at 
25 ºC in 96-well plates in a total volume of 0.3 mL. Measurements of kinetic parameters 
for FBP were performed with 5.3 μg/mL of purified protein at sixteen different FBP 
concentrations in the range 0.005-0.25 mM. Assays to determine the kinetic parameters 
for DHA were performed with 24 μg/mL of purified DLF at twelve concentrations of 
substrate under saturating concentrations of [MgATP]2- complex (3.75 mM). Steady-
state kinetic assays with FBPA were carried out as well at 25 ºC in 96-well plates in a 
total volume of 0.3 mL. Measurements of kinetic parameters for FBP were performed 
with 0.83 μg/mL of purified protein at twenty different FBP concentrations in the range 
0.005-0.6 mM. Kinetic constants were obtained using the built-in nonlinear regression 
tools in SigmaPlot 8.0. For the determination of apparent kinetic constants (variation of 
only one substrate), initial velocities (Vi) were fitted to the Michaelis-Menten equation. 
Substrate Channeling Assay: To study the possible substrate channelling promoted by 
the proximity of the active centres in the fused enzyme, the rates of the coupled reaction 
catalysed by DLF or a combination of the two parent enzymes were measured and 
compared under same conditions. In both cases, 0.91 U of kinase activity and 2.66 U of 
aldolase activity were used. To fit the Units of activity was necessary to use a slightly 
higher amount of DLF in terms of mg of protein. Thus, 0.49 mg of DLF was used by a 
total of 0.175 mg for the sum of DHAK (0.114 mg) and FBPA (0.061). The reactions 
were carried out at room temperature in 1.5 mL of phosphate buffer (20 mM, pH 7.5) 
containing 0.05 mmol of DHA, 0.15 mmol of benzyloxyacetaldehyde (1), 12.5 μmol of 
MgSO4 and 12.5 μmol of ATP. At different time, 50 μL aliquots were taken. The 
reaction was stopped with HClO4 (7%) and the aldol product formed quantified by the 
retro-aldol assay. In the DHAP trapping experiment, GDH activity was measured in 
competition with the coupled reactions catalysed by DLF or by the multi-enzyme 
system. GDH activity was measured spectrophotometrically following the decrease of 
absorbance at 340 nm due to NADH oxidation for 10 minutes. In all cases, 0.04 U of 
kinase activity and 0.12 U of aldolase activity were used. The reactions were carried out 
at room temperature in 1 mL of phosphate buffer (20 mM, pH 7.5) containing 2.5 μmol 
of DHA, 7.5 μmol of acetaldehyde (2), 5 μmol of MgSO4, 0.2 μmol of NADH, 3.75 
μmol of ATP and different amounts of GDH in the range 0.231-33.99 μg. 
Synthetic application of the bifunctional DLF enzyme: C-C bond formation reactions 
catalysed by the fusion enzyme DLF, were carried out at room temperature in 1.5 mL of 
phosphate buffer (20 mM, pH 7.5) containing 0.05 mmol of DHA, 0.15 mmol of 
aldehyde acceptor (benzyloxyacetaldehyde (1), acetaldehyde (2) and 3-
(methylthio)propionaldehyde (3) respectively), 0.1 mmol of acetyl phosphate, 12.5 
μmol of MgSO4, 3 U of AK and DLF (1.5-2 U and 3-6 U of kinase and aldolase 
activities respectively). The reactions begin with the addition of 3.4 μmol of ATP. 
When the consumption of DHA was higher than 90 % (~20 h), the reactions were 
stopped and passed through activated carbon. The eluted was freeze-dried for NMR 
characterization. The determination of the stereoisomeric products formed by 
bifuctional DLF was carried out following the method described by Sheldon and co-
workers.[37]  
5-(benzyloxy)-3,4-dihydroxy-2-oxopentyl phosphate (4): 1H NMR (500 MHz, D2O, 
298 K): δ 7.2-7.1 (m, 5H, Ar), 4.52 (dd, 1H, J= 18.5, 5.8 Hz, H-1A), 4.40 (dd, 1H, J= 
18.5, 5.8 Hz, H-1B); 4.4-4.3 (m, 2H, CH2Ph), 4.29 (s, 1H, H-3), 4.15-4.05 (m, 1H, H-4), 
3.50-3.45 (m, 1H, H-5A), 3.45-3.40 (m, 1H, H-5B). 13C RMN (125 MHz, D2O, 298 K): δ 
212.3 (C-2), 129.5 (Ar), 129.3 (Ar), 128.9 (Ar), 128.6 (Ar), 75.5 (C-1); 73.1 (C-5); 72.4 
(CH2Ph); 70.5 (C-4); 70.2 (C-3). 
3,4-dihydroxy-2-oxopentyl phosphate (5): 1H NMR (500 MHz, D2O, 298 K): δ 4.55 
(dd, 1H, J= 18.8, 6.1 Hz, H-1A), 4.45 (dd, 1H, J= 18.8, 6.1 Hz, H-1B); 4.20 (d, 1H, J= 
2.6 Hz, H-3); 4.14 (dq, 1H, J= 6.4, 2.4 Hz, H-4), 1.10 (d, 3H, J= 6.3 Hz, Me). 13C NMR 
(125 MHz, D2O, 298 K): δ 211.6 (C-2), 78.5 (C-3), 67.9 (C-4), 67.7 (C-1), 18.4 (Me). 
3,4-dihydroxy-6-(methylthio)-2-oxohexyl phosphate (6): 1H NMR (500 MHz, D2O, 
298 K): δ 4.55 (dd, 1H, J= 18.8, 6.6 Hz, H-1A), 4.45 (dd, 1H, J= 18.8, 6.6 Hz, H-1B); 
4.28 (d, 1H, J= 2.2 Hz, H-3); 4.05 (ddd, 1H, J= 14.4, 11.5, 9.2 Hz, H-4), 2.5-2.4 (m, 2H, 
H-6), 1.95 (s, 3H, Me), 1.8-1.7 (m, 2H, H-5). 13C NMR (125 MHz, D2O, 298 K): δ 211.5 
(C-2), 77.7 (C-3), 70.4 (C-4), 68.1 (C-1), 29.6 (C-6), 23.5 (C-5); 14.3 (Me). 
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SFigura 1. CD spectra at 20 ºC of DHAK (A); FBPA (B) and DLF (C). The dots represent the 
experimental data and the lines show the theoretical spectra calculated with: (1) CONTIN, (2) 
SELCON3 (3) CDSSTR 
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SFigura 2. CD spectra at 20 ºC of a DHAK:FBPA mixture (mol:mol). The dots represent the 
experimental data and the lines show the theoretical spectra calculated with: (1) CONTIN, (2) 
SELCON3 (3) CDSSTR 
 
190 200 210 220 230 240
-20000
-15000
-10000
-5000
0
5000
10000
15000
20000
25000
 
 
[Θ
] M
R
W
 (d
eg
 c
m
2  d
m
ol
-1
)
λ (nm)
 T20
 T30
 T40
 T45
 T50
 T55
 T60
 T65
 T70
 T75
 T80
 T90
190 200 210 220 230 240
-30000
-20000
-10000
0
10000
20000
30000
40000
 
 
[Θ
] M
R
W
 (d
eg
 c
m
2  d
m
ol
-1
)
λ (nm)
 T20
 T30
 T40
 T45
 T50
 T55
 T60
 T65
 T70
 T75
 T80
 T90
190 200 210 220 230 240
-15000
-7500
0
7500
15000
22500
 
 
[Θ
] M
R
W
 (d
eg
 c
m
2  d
m
ol
-1
)
λ (nm)
 T20
 T30
 T40
 T50
 T60
 T70
 T80
 T90
190 200 210 220 230 240
-15000
0
15000
30000
 
 
[Θ
] M
R
W
 (d
eg
 c
m
2  d
m
ol
-1
)
λ (nm)
 T20
 T30
 T40
 T45
 T50
 T55
 T60
 T65
 T70
 T75
 T80
 T90
(a) (b)
(c) (d)
 
SFigura 3. CD spectra at different temperatures of (a) DHAK, (b) FBPA, (c) DLF and (d) 
equimolar mixture of DHAK and FBPA used to calculate the fraction of unfolding fu.  
